Graves' Disease
123
36
39
57
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Research Maturity
57 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
4 terminated out of 123 trials
93.4%
+6.9% vs benchmark
15%
18 trials in Phase 3/4
16%
9 of 57 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 57 completed trials
Clinical Trials (123)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Prospective Evaluation of OptiThyDose
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Thyroid Disorders in Pediatric Autoimmune Hepatitis
Natural History of Thyroid Function Disorders
Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
Preoperative Corticosteroids in Autoimmune Thyroid Disease
Study of BHV-1300 in Graves' Disease